Neuberger Berman Group’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.08M Buy
77,093
+5,715
+8% +$363K ﹤0.01% 977
2025
Q4
$4.54M Buy
71,378
+65,069
+1,031% +$4.05M ﹤0.01% 992
2025
Q3
$347K Buy
6,309
+132
+2% +$5.44K ﹤0.01% 1710
2025
Q2
$204K Sell
6,177
-513
-8% -$17.8K ﹤0.01% 1884
2025
Q1
$269K Buy
+6,690
New +$307K ﹤0.01% 1736
2024
Q4
Sell
-3,874
Closed -$205K 1950
2024
Q3
$205K Sell
3,874
-91,492
-96% -$5.1M ﹤0.01% 1789
2024
Q2
$5.17M Buy
95,366
+17,364
+22% +$1.05M ﹤0.01% 902
2024
Q1
$5.47M Buy
78,002
+16,779
+27% +$1.3M ﹤0.01% 900
2023
Q4
$5.11M Buy
61,223
+13,729
+29% +$497K ﹤0.01% 908
2023
Q3
$1.4M Buy
47,494
+2,108
+5% +$70.2K ﹤0.01% 1164
2023
Q2
$1.48M Buy
45,386
+22,227
+96% +$822K ﹤0.01% 1149
2023
Q1
$815K Buy
+23,159
New +$945K ﹤0.01% 1316

Other funds holding CYTK